黄芩苷在小鼠急性高眼压青光眼模型中的作用及机制
该研究通过小鼠急性高眼压模型和体外氧糖剥夺/再灌注(OGD/R)模型,探讨黄芩苷对视网膜神经节细胞(RGC)的保护作用及机制。结果显示黄芩苷可减轻视网膜损伤、提高RGC存活率,并抑制炎性因子表达。
要点
- 急性高眼压小鼠视网膜厚度随时间下降,3、5、7天分别降至87.32%、74.86%、63.53%。
- 50 mg/kg黄芩苷预处理使高眼压后5天RGC存活率从61.32%提高至89.93%。
- 黄芩苷通过抑制TNF-α、IL-1β、iNOS表达及减少小胶质细胞IL-1β释放保护RGC。
核心结论
- 黄芩苷在体内急性高眼压模型和体外OGD/R模型中可直接减轻视网膜及RGC损伤,并通过抑制炎性因子表达发挥RGC保护作用。
研究设计与样本
- 实验研究,使用SPF级C57BL/6小鼠建立急性高眼压模型,并体外培养原代RGC及BV2小胶质细胞共培养体系。
主要发现
- 急性高眼压后视网膜厚度3天降至87.32%±0.94%(t=6.73,P<0.01),5天降至74.86%±2.43%(t=13.40,P<0.01),7天降至63.53%±2.15%(t=19.46,P<0.01)。
- 高眼压后5天RGC存活率降至61.32%±5.94%,50 mg/kg黄芩苷预处理后提高至89.93%±10.08%(t=4.84,P<0.01)。
- 黄芩苷干预后急性高眼压模型视网膜中TNF-α、IL-1β、iNOS表达降低。
- 体外OGD/R后原代RGC存活率降至51.53%±1.36%,5.0和10.0 μmol/L黄芩苷预处理后分别提高至69.37%±7.09%和66.23%±4.25%(t=5.50、4.53,均P<0.01)。
- BV2共培养OGD/R后RGC存活率为41.83%±3.55%,低于单纯RGC培养的51.33%±1.16%(t=4.96,P=0.042);5.0 μmol/L黄芩苷使BV2分泌IL-1β从(61.33±5.78)pg/ml降至(39.97±8.76)pg/ml(t=4.19,P=0.010),并将RGC存活率提高至73.00%±5.20%(t=2.82,P=0.048)。
临床怎么用
- 黄芩苷可能通过抗炎和直接保护RGC途径,为急性高眼压相关青光眼损伤提供潜在神经保护策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the potential neuroprotection effects and associated mechanism of baicalin in a rodent acute hypertensive glaucoma model and oxygen-glucose deprivation/reperfusion (OGD/R) induced retinal ganglion cell (RGC) injury. Methods: Experiment research. A rapid and substantial elevation of intraocular pressure was performed to establish an acute hypertensive glaucoma model, and retinal thickness was assessed at 1, 3, 5, and 7 days. The mice were then randomly divided into three groups: normal control group, hypertension group, and baicalin (50 mg/kg) for hypertension group. The effects of baicalin on the RGCs were evaluated by retrograde transporting of Fluoro-Gold. The mRNA levels of tumor necrosis factor-α, interleukine-1β (IL-1β), and inducible nitric oxide synthase were detected by real-time PCR, and the protein levels were measured by Western blot in the retina tissue of acute hypertensive glaucoma model. Purified primary RGC survival under OGD/R stress was measured by flow cytometry, which was also performed to measure the survival rate of RGCs pretreated by different doses of baicalin (2.5 μmol/L, 5.0 μmol/L, and 10.0 μmol/L). The effects of baicalin on primary RGCs co-cultured with mouse microglia cell line BV2 were evaluated by flow cytometry. The cytokine IL-1β in the culture supernatant was measured by immunochemical analyses. Statistical analysis was performed using analysis of variance. Results: Retinal tissue injuries and RGC loss were observed both in vivo and in vitro. Retinal thickness was decreased to 87.32%±0.94% at 3 days (t=6.73, P<0.01), 74.86%±2.43% at 5 days (t=13.40, P<0.01), and 63.53%±2.15% at 7 days (t=19.46, P<0.01). Treatment of 50 mg/kg baicalin significantly promoted the RGC survival from 61.32%±5.94% to 89.93%±10.08% (t=4.84, P<0.01). Baicalin alleviated the retinal damages by suppressing the expression of inflammatory cytokines as revealed by Western blot and real-time PCR. In vitro the RGC survival under OGD/R stress was increased from 51.53%±1.36% to 69.37%±7.09% and 66.23%±4.25% with 5.0, 10.0 μmol/L baicalin administration (t=5.50, 4.53; both P<0.01). BV2 under OGD/R stress did extra damage to RGCs, and baicalin could reverse the damages and increase the survival from 69.37%±7.09% to 73.00%±5.20% (t=2.82, P=0.048) by reducing the release of IL-1β [(39.97±8.76) pg/ml vs. (61.33±5.78) pg/ml, t=4.19, P=0.010]. Conclusion: Baicalin could alleviate retina tissue injury directly and promote the survival of RGCs by downregulating the expression of inflammatory cytokines and protecting RGCs from ischemia reperfusion injury. (Chin J Ophthalmol, 2020, 56: 376-382). 目的: 探讨黄芩苷在体内急性高眼压模型及体外氧糖剥夺/再灌注(OGD/R)模型视网膜神经节细胞(RGC)死亡中的作用及其机制。 方法: 实验研究。取SPF级C57BL/6小鼠,通过前房灌注平衡盐溶液建立急性高眼压模型,于建模后不同时间点(分为对照组及急性高眼压后1、3、5、7 d组,每组取5只小鼠)取材评估视网膜损伤程度;同时联合荧光金上丘逆行标记RGC计数,评价尾静脉注射50 mg/kg黄芩苷对急性高眼压建模5 d时RGC损伤的作用。利用Western印迹、实时荧光定量PCR法检测小鼠急性高眼压模型视网膜炎性反应因子的表达。体外培养纯化的原代RGC,建立OGD/R模型,流式细胞术评价不同浓度(2.5、5.0、10.0 μmol/L)黄芩苷对RGC存活率的影响。建立小鼠小胶质细胞BV2细胞和原代RGC共培养体系,在OGD/R模型下,酶联免疫吸附试验检测BV2细胞炎性反应因子的分泌,评估黄芩苷对BV2细胞的作用及RGC存活的影响。采用方差分析进行统计学分析。 结果: 在小鼠急性高眼压模型中可观察到视网膜厚度变薄,建模后3 d厚度下降至87.32%±0.94%(t=6.73,P<0.01),5 d后厚度降至74.86%±2.43%(t=13.40,P<0.01),7 d后仅为63.53%±2.15%(t=19.46,P<0.01),差异有统计学意义。荧光金上丘逆行标记RGC计数同样观察到急性高眼压建模后5 d RGC存活率下降至61.32%±5.94%(t=6.59,P<0.01),给予尾静脉注射50 mg/kg黄芩苷预处理后,RGC的存活率提高至89.93%±10.08%(t=4.84,P<0.01)。Western印迹、实时荧光定量PCR检测急性高眼压建模后炎性反应因子肿瘤坏死因子α、白细胞介素1β、诱导性一氧化氮合酶的表达,均有不同程度的增高,黄芩苷干预后炎性反应因子的表达降低。同样,在体外OGD 2 h/R 6 h后原代RGC存活率下降至51.53%±1.36%(t=14.91,P<0.01),5.0、10.0 μmol/L黄芩苷预处理后存活率提高至69.37%±7.09%、66.23%±4.25%(t=5.50,4.53;均P<0.01),差异有统计学意义。在BV2细胞和RGC共培养体系下,OGD 2 h/R 6 h后RGC的存活率为41.83%±3.55%,低于单纯RGC培养OGD 2 h/R 6 h后RGC的存活率51.33%±1.16%(t=4.96,P=0.042);5.0 μmol/L黄芩苷预处理后,可减轻BV2细胞分泌白细胞介素1β,由(61.33±5.78)pg/ml降至(39.97±8.76)pg/ml(t=4.19,P=0.010),且与5.0 μmol/L黄芩苷预处理后单纯RGC培养(69.37%±7.09%)比,可提高RGC存活率至73.00%±5.20%(t=2.82,P=0.048)。 结论: 体内急性高眼压模型、体外单纯OGD/R模型下,黄芩苷可直接减轻视网膜及RGC损伤,并通过抑制视网膜炎症细胞炎性反应因子的表达,发挥保护RGC的作用。(中华眼科杂志,2020,56:376-382).
引用
- Zhang YY, Li ZD, Jiang N, et al. [The effects and mechanism of baicalin in a mouse acute hypertensive glaucoma model]. Zhonghua Yan Ke Za Zhi. 2020. PMID: 32450671. doi:10.3760/cma.j.cn112142-20200107-00011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。